Conversational-amplified prompt engineering (CAPE) is gaining interest and use by savvy generative AI users. I explain how it ...

The Company's lead drug candidate, ISP-001, is the first ever engineered B cell in a human clinical trial and a first-in-class investigational treatment for mucopolysaccharidosis type I (MPS I), a ...

Tattoos are one of the methods used to assert control over victims, experts say. A new Tennessee bill could require tattoo artists to get training on recognizing the signs of human trafficking and ...

Richland, WA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to report that the first five patients demonstrated the safety of RadioGel Precision Radionuclide Therapy TM by ...

Statement of CEO Mike Korenko: “After years of dedicated effort, we are thrilled with these initial clinical trial results and optimistic about future findings. As the study progresses ...

Since the pandemic, drug trials that purposely make people vomit ... Specifically, he had agreed to take part in a human challenge trial, a research method in which volunteers are knowingly ...

Dr. Hing C. Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a ...

The company also announced a contract with hVIVO (AIM: HVO), a fast-growing specialist contract research organization and the world leader in human challenge trials, to conduct the Phase 2a trial.

Several FSI OneVoice panels that were on the topic of artificial intelligence and most BD's know they must up their game.